Professional Documents
Culture Documents
Handout On Neoplasia
Handout On Neoplasia
1
Neoplasia
3
Feature Benign Malignant
6
Classification of Neoplasms
B. Malignant tumors-
suffix “carcinoma” applied to epithelial cancers.
“sarcoma” to those of mesenchymal origin.
7
Classification of Neoplasms
Tissue Differentiation Benign Malignant
9
Classification of Neoplasms
B. Malignant tumors-
-secondary descriptors refer to tumor’s morphological and
functional characteristics.
inability to invade
-definition resides above all in an
adjacent tissue and to metastasize.
11
12
Histological Diagnosis of
Malignancy
Malignant tumors
-depart from parent tissue morphologically and functionally but
diagnosis depends on resemblance to normal tissue .
-features the favor malignancy:
(1) anaplasia or cellular atypia.
-lack of differentiated features in a cancer cell.
-degree correlates with aggresiveness.
-cytological evidence include variation in size and shape
(pleomorphism), enlarged hyperchromatic nuclei with
clumped chromatin pattern and prominent nucleoli, atypical
mitosis, bizarre cells. 13
If cells LOOK BAD, they are probably going to
BEHAVE BAD!
14
“ANAPLASIA”
Pleomorphism
Size
shape
Chromatin clumping
Prominent nucleoli
Mitoses
Mitotic rate
Location of mitoses
15
Loss of polarity
16
Histological Diagnosis of
Malignancy
Malignant tumors
17
Features of Malignant Tumors
(1) Cellular features
-anaplasia
(2) Local invasion
-capsule
-basement membrane
(3) Metastasis
-unequivocal sign of malignancy
-seeding of body cavities
-lymphatic and hematogenous spread
18
Breast carcinoma
19
Breast carcinoma
20
Breast carcinoma
21
Breast carcinoma
22
Breast carcinoma –lymph node
metastasis
23
Breast carcinoma –liver metastasis
24
Histological Diagnosis of
Malignancy
Electron Microscopy of Tumors
-no specific determinants of malignancy can be detected by
electron microscopy.
-significant value in diagnosis of poorly differentiated
cancers problematic by routine microscopy.
25
Histological Diagnosis of
Malignancy
Electron Microscopy of Tumors
28
Histological Diagnosis of
Malignancy
Tumor Markers
(4) Soft tissue sarcomas –express vimentin.
desmin smooth or striated muscle fibers.
muscle-specific actin marker for muscle tissue.
neurofilament proteins neuroblastomas and ganglioneuromas
glial fibrillary acidic protein astrocytes.
30
Histological Diagnosis of
Malignancy
Tumor Markers
A. Direct Extension
-in-situ stage – carcinomas confined to the epithelium; no
penetration of basement membrane; not defined for
connective tissue cells, lymphoid elements, and hepatocytes.
2. lymphatic metastasis
-basement membranes are lacking in lymphatic capillaries.
-regional lymphatic pattern of spread.
34
Invasion and Metastasis
C. Biology of invasion and spread
36
37
Invasion and Metastasis
(1) invasion
-role of adhesion molecules:
integrins –confers metastatic potential; play a role in cell
migration, proliferation, and in angiogenesis.
expression of intercellular adhesion molecule-1 (ICAM-1)
correlates with tumor aggresiveness.
vascular cell adhesion molecule-1 (VCAM-1) is downregulated
in highly metastatic clones; decreased expression allows
detachment of tumor cells from parent tumor.
cadherins and catenins –cell-cell adhesion molecules that
suppress invasion and metastasis; expression lost or
reduced in most carcinomas. 38
Invasion and Metastasis
(1) invasion
39
Invasion and Metastasis
(2) Metastasis
41
The Grading and Staging of
Cancers
A. Cancer Grading
-subjective and semi-quantitative.
-based on the degree of anaplasia and number of proliferating
cells.
(i) degree of anaplasia: shape and regularity of cells,
presence and distinct differentiated features
3. Local invasion
4. Distant metastases. 44
Dysplasia
-literally means abnormal growth.
-in dysplasia ,some but not all of the features of malignancy are
present microscopically.
46
47
48
Tumor Growth Rate
-doubling time of tumor cells
lengthens as tumor grows
30 doublings (109 cells) = 1 g
10 more doublings (1 kg) = lethal burden
-fraction of tumor cells in replicative pool
may be only 20% even in rapidly growing tumors
tumor stem cells
-rate at which tumor cells are shed or lost
apoptosis
maturation
49
“clonal”
50
Schematic Representation Of
Tumor Growth
51
Geographic & Environmental
Sun exposure
Melanomas 6x incidence New Zealand vs Iceland
Blacks have low incidence of melanoma, so do normally
pigmented areas like areola on white people
Smoking and alcohol abuse
Body mass
Overweight = 50% increase in cancer
52
Geographic & Environmental
53
Change In Incidence Of Various Cancers
With Migration From Japan To The United
States
54
Predisposing Factors for Cancer
Age
Most cancers occur in persons ≥ 55 years
Childhood malignancies
Leukemias & CNS neoplasms
Bone tumors
Genetic predisposition
Familial cancer syndromes
Early age at onset
56
The Growth of Cancer
A. Cell cycle kinetics
-tumor cells do not necessarily proliferate at a faster rate than
their normal counterparts.
-major determinant of tumor growth is more
cells
produced than die in a given time.
Doubling time-
-time taken for number of cells in mass to double.
57
The Growth of Cancer
B. Tumor Angiogenesis
-sprouting of new capillaries from pre-existing blood vessels;
requirement for continued growth of cancers.
C. Tumor Dormancy
-cell proliferation is balance by apoptosis in the absence of
tumor angiogenesis; or may be due to cell cycle arrest.
59
The Molecular Genetics of Cancer
60
The Molecular Genetics of Cancer
-likely the most common mechanism of mutagenesis
relates to spontaneous errors in DNA replication
and repair.
63
The Molecular Genetics of Cancer
64
The Molecular Genetics of Cancer
A. Oncogenes
2. Mechanisms of actions of oncogenes
65
The Molecular Genetics of Cancer
A. Oncogenes
2. Mechanisms of actions of oncogenes
66
The Molecular Genetics of Cancer
B. Tumor Suppressor Genes
-loss of heterozygosity by deletion or somatic mutation
predispose to tumor development.
P53 gene
-located on small arm of chromosome 17; protein product
present in all normal tissues.
-seem to be the most common genetic change in human cancer
(deleted or mutated in 80% of cases of colon cancer,
frequently in breast cancer, small cell carcinoma of lung,
hepatocellular carcinoma, astrocytoma).
-negative regulator of cell division; levels rise in response to DNA
damage and prevent cells from entering the S phase allowing
time for DNA repair to take place.
-mutations allow cells with damage DNA to
67
progress through the cycle.
The Molecular Genetics of Cancer
B. Tumor Suppressor Genes
68
The Molecular Genetics of Cancer
C. Mutator Genes
-caretaker genes which exercise surveillance over the
integrity of genetic information by participating in cellular
response to DNA damage.
69
Viruses and Human Cancer
It is estimated that viral infections are responsible for 15% of all
human cancers.
70
Hepatocellular carcinoma
71
Burkitt’s lymphoma
72
Chemical carcinogenesis
Many compounds known to be potent carcinogens are relatively
inert in terms of chemical reactivity; most require
metabolic activation before they can react with cell
constituents.
75
Bronchogenic carcinoma
76
Bladder carcinoma
77
Physical carcinogenesis
A. UV radiation
-cancers attributed to sun exposure, namely: (1) basal cell
carcinoma, (2) squamous cell carcinoma, (3) melanoma.
-areas exposed to the sun are most prone to develop cancer.
-there is distinct correlation between total exposure to sunlight
and the incidence of cancer.
-carcinogenic effect occurs at wavelengths of 290nm to 320
nm.
-the effects of radiation on cells include enzyme inactivation,
inhibition of cell division, mutagenesis, cell death, and
cancer.
-most important biochemical effect is the formation of
pyramidine dimers on DNA which distorts the
backbone of the DNA helix (unless repaired; this genomic
78
injury is mutagenic and carcinogenic).
Basal cell carcinoma
79
Physical carcinogenesis
B. Asbestos
80
Malignant mesothelioma
81
Epidemiology of Cancer
82
Epidemiology of Cancer
83
Epidemiology of Cancer
84
Epidemiology of Cancer
85
Epidemiology of Cancer
86
87